Status:
COMPLETED
Information About Alzheimer's Disease for Latinos in New York City
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Alzheimer Disease
Eligibility:
All Genders
40-64 years
Phase:
NA
Brief Summary
This study will assess the psychosocial and behavioral impacts of receiving Alzheimer's disease genetic risk assessment incorporating APOE genotypes among Latinos in northern Manhattan. The investigat...
Detailed Description
Apolipoprotein E (APOE) is the strongest genetic predictor of risk for late-onset Alzheimer's disease (AD). Given the high level of interest in genetic testing, the demand for predictive testing for A...
Eligibility Criteria
Inclusion
- self-identified as Latino or Hispanic
- age 40-64 years
- current residence in target neighborhoods: Washington Heights, Inwood, Hamilton Heights, Central Harlem, East Harlem, Morningside Heights, Manhattanville, or Striver's Row, New York
Exclusion
- does not self-identify as Latino
- does not reside in target neighborhoods
- not in applicable age range
- has Alzheimer's disease
- previously tested for APOE
- has a family history consistent with autosomal dominant, early onset Alzheimer's disease
- has a positive screen for suicidality in Baseline Survey (any response other than "not at all" to PHQ-9 item, "thoughts that you would be better off dead or of hurting yourself in some way")
Key Trial Info
Start Date :
August 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2025
Estimated Enrollment :
374 Patients enrolled
Trial Details
Trial ID
NCT04471779
Start Date
August 13 2021
End Date
October 3 2025
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032